Tag Archives: Donepezil (Aricept)

Dementia Drug Effective in Helping Avoid Transitions into Care Homes (MRC / BBC News / Lancet Neurology)

Summary Analysis of data from the DOMINO-AD Trial indicates that the drug Donepezil may be effective in avoiding care home admissions in more advanced cases of Alzheimer’s Disease. Discontinuation of donepezil appears to be associated with an increased risk of … Continue reading

Posted in Alzheimer's Society, BBC News, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Patient Care Pathway, Patient Information, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Scotland, Statistics, UK, Universal Interest | Tagged , , , , , , , , , , | Leave a comment

Pharmacist-Based Donepezil Outpatient Consultation Service (Patient Preference and Adherence)

[A brief reference to this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012]. Summary Donepezil delays the progression of cognitive dysfunction in Alzheimer’s Disease (AD), but the efficacy of pharmacotherapy … Continue reading

Posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Cholinesterase Inhibitors for Dementia with Lewy Bodies, Parkinson’s Disease Dementia and Cognitive Impairment in Parkinson’s Disease (Cochrane Library)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 9, April 2012]. Summary Earlier Cochrane reviews have examined the use of cholinesterase inhibitors in both Parkinson’s Disease with dementia (PDD) and dementia with … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (NICE)

[A version of this abstract appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 1 Issue 9, April 2011]. Abstract Note: The long-awaited review and re-appraisal of Donepezil, Galantamine, Rivastigmine and Memantine for the treatment of Alzheimer’s Disease has resulted in changes to … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, Management of Condition, National, NICE Guidelines, Pharmacological Treatments, Practical Advice, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , | Leave a comment